Christine A Rehr1,2, Adrian Wong1,3, Diane L Seger1,2, David W Bates1,2,4. 1. Department of General Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States. 2. Clinical and Quality Analysis, Partners HealthCare, Somerville, Massachusetts, United States. 3. Massachusetts College of Pharmacy and Health Systems University, Boston, Massachusetts, United States. 4. Harvard Medical School, Boston, Massachusetts, United States.
Abstract
OBJECTIVE: This article aims to understand provider behavior around the use of the override reason "Inaccurate warning," specifically whether it is an effective way of identifying unhelpful medication alerts. MATERIALS AND METHODS: We analyzed alert overrides that occurred in the intensive care units (ICUs) of a major academic medical center between June and November 2016, focused on the following high-significance alert types: dose, drug-allergy alerts, and drug-drug interactions (DDI). Override appropriateness was analyzed by two independent reviewers using predetermined criteria. RESULTS: A total of 268 of 26,501 ICU overrides (1.0%) used the reason "Inaccurate warning," with 93 of these overrides associated with our included alert types. Sixty-one of these overrides (66%) were identified to be appropriate. Twenty-one of 30 (70%) dose alert overrides were appropriate. Forty of 48 drug-allergy alert overrides (83%) were appropriate, for reasons ranging from prior tolerance (n = 30) to inaccurate ingredient matches (n = 5). None of the 15 DDI overrides were appropriate. CONCLUSION: The "Inaccurate warning" reason was selectively used by a small proportion of providers and overrides using this reason identified important opportunities to reduce excess alerts. Potential opportunities include improved evaluation of dosing mechanisms based on patient characteristics, inclusion of institutional dosing protocols to alert logic, and evaluation of a patient's prior tolerance to a medication that they have a documented allergy for. This resource is not yet routinely used for alert tailoring at our institution but may prove to be a valuable resource to evaluate available alerts. Schattauer GmbH Stuttgart.
OBJECTIVE: This article aims to understand provider behavior around the use of the override reason "Inaccurate warning," specifically whether it is an effective way of identifying unhelpful medication alerts. MATERIALS AND METHODS: We analyzed alert overrides that occurred in the intensive care units (ICUs) of a major academic medical center between June and November 2016, focused on the following high-significance alert types: dose, drug-allergy alerts, and drug-drug interactions (DDI). Override appropriateness was analyzed by two independent reviewers using predetermined criteria. RESULTS: A total of 268 of 26,501 ICU overrides (1.0%) used the reason "Inaccurate warning," with 93 of these overrides associated with our included alert types. Sixty-one of these overrides (66%) were identified to be appropriate. Twenty-one of 30 (70%) dose alert overrides were appropriate. Forty of 48 drug-allergy alert overrides (83%) were appropriate, for reasons ranging from prior tolerance (n = 30) to inaccurate ingredient matches (n = 5). None of the 15 DDI overrides were appropriate. CONCLUSION: The "Inaccurate warning" reason was selectively used by a small proportion of providers and overrides using this reason identified important opportunities to reduce excess alerts. Potential opportunities include improved evaluation of dosing mechanisms based on patient characteristics, inclusion of institutional dosing protocols to alert logic, and evaluation of a patient's prior tolerance to a medication that they have a documented allergy for. This resource is not yet routinely used for alert tailoring at our institution but may prove to be a valuable resource to evaluate available alerts. Schattauer GmbH Stuttgart.
Authors: Adrian Wong; Mary G Amato; Diane L Seger; Christine Rehr; Adam Wright; Sarah P Slight; Patrick E Beeler; E John Orav; David W Bates Journal: BMJ Qual Saf Date: 2018-02-09 Impact factor: 7.035
Authors: Adrian Wong; Mary G Amato; Diane L Seger; Sarah P Slight; Patrick E Beeler; Patricia C Dykes; Julie M Fiskio; Elizabeth R Silvers; E John Orav; Tewodros Eguale; David W Bates Journal: J Crit Care Date: 2017-02-20 Impact factor: 3.425
Authors: Eric A J Hoste; Sean M Bagshaw; Rinaldo Bellomo; Cynthia M Cely; Roos Colman; Dinna N Cruz; Kyriakos Edipidis; Lui G Forni; Charles D Gomersall; Deepak Govil; Patrick M Honoré; Olivier Joannes-Boyau; Michael Joannidis; Anna-Maija Korhonen; Athina Lavrentieva; Ravindra L Mehta; Paul Palevsky; Eric Roessler; Claudio Ronco; Shigehiko Uchino; Jorge A Vazquez; Erick Vidal Andrade; Steve Webb; John A Kellum Journal: Intensive Care Med Date: 2015-07-11 Impact factor: 17.440
Authors: Marilyn D Paterno; Saverio M Maviglia; Paul N Gorman; Diane L Seger; Eileen Yoshida; Andrew C Seger; David W Bates; Tejal K Gandhi Journal: J Am Med Inform Assoc Date: 2008-10-24 Impact factor: 4.497
Authors: Tyken C Hsieh; Gilad J Kuperman; Tonushree Jaggi; Patricia Hojnowski-Diaz; Julie Fiskio; Deborah H Williams; David W Bates; Tejal K Gandhi Journal: J Am Med Inform Assoc Date: 2004-08-06 Impact factor: 4.497
Authors: Insook Cho; Sarah P Slight; Karen C Nanji; Diane L Seger; Nivethietha Maniam; Patricia C Dykes; David W Bates Journal: BMC Nephrol Date: 2014-12-15 Impact factor: 2.388
Authors: Jeritt G Thayer; Jeffrey M Miller; Alexander G Fiks; Linda Tague; Robert W Grundmeier Journal: Appl Clin Inform Date: 2019-04-03 Impact factor: 2.342
Authors: Adrian Wong; Christine Rehr; Diane L Seger; Mary G Amato; Patrick E Beeler; Sarah P Slight; Adam Wright; David W Bates Journal: Drug Saf Date: 2019-04 Impact factor: 5.606
Authors: Pierre Elias; Eric Peterson; Bob Wachter; Cary Ward; Eric Poon; Ann Marie Navar Journal: Appl Clin Inform Date: 2019-11-27 Impact factor: 2.342
Authors: Timothy S Chang; Ashwin Buchipudi; Gregg C Fonarow; Michael A Pfeffer; Jennifer S Singer; Eric M Cheng Journal: Appl Clin Inform Date: 2019-06-19 Impact factor: 2.342
Authors: Adam Wright; Dustin S McEvoy; Skye Aaron; Allison B McCoy; Mary G Amato; Hyun Kim; Angela Ai; James J Cimino; Bimal R Desai; Robert El-Kareh; William Galanter; Christopher A Longhurst; Sameer Malhotra; Ryan P Radecki; Lipika Samal; Richard Schreiber; Eric Shelov; Anwar Mohammad Sirajuddin; Dean F Sittig Journal: J Am Med Inform Assoc Date: 2019-10-01 Impact factor: 4.497